Enduring Material

Cholestatic Liver Disease: PBC, PSC, and Pruritus
View Activity Info
Enter Basic User Info
Create Account
View Content
Take Post Test
Done
View Activity Info
 
 
Colorado Medical Society

7351 Lowry Blvd, Suite 110
Denver, CO 80230-6902
General Information
Monday, July 13, 2026 - Friday, October 1, 2027
60 minutes
SC Liver Research Consortium
Virtual Conference Room
Cholestatic Liver Disease: PBC, PSC, and Pruritus
Colorado Medical Society
Objectives
  • Understand new and emerging therapies for Primary Biliary Cholangitis; methods of action and potential benefits.
  • Manage Pruritus in your PBC patients.
  • Review the three prominent forms of PBC and recognize similarities and differences.
Presentations and Speakers
Available Credits/Points
  • The Colorado Medical Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The Colorado Medical Society designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statements
Planners and other Administrative Support:
Paul Pockros, MD, Hepatology has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Gilead - Speakers Bureau - Relationship Has Not Ended
  • Gilead - Advisory Committee Member - Relationship Has Not Ended
  • Ipsen - Speakers Bureau - Relationship Has Not Ended
  • Ipsen - Advisory Committee Member - Relationship Has Not Ended
  • Madrigal - Advisory Committee Member - Relationship Has Not Ended
  • Madrigal - Speakers Bureau - Relationship Has Not Ended
  • Novo - Speakers Bureau - Relationship Has Not Ended
  • Mirum - Consulting - Relationship Has Not Ended
  • Intercept - Consulting - Relationship Ended
  • Orphalan - Advisory Committee Member - Relationship Has Not Ended
  • Boston Pharmaceuticals - Review Panel Member - Relationship Ended
  • f5 Therapeutics - Board Member - Relationship Has Not Ended
Brian T Lee, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
  • Ipsen - Advisory Committee Member - Relationship Ended

Colorado Medical Society and SC Liver Research Consortium acknowledges Gilead Sciences and Ipsen Bioscience for their commercial support of this educational activity.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and the SC Liver Research Consortium The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
Test Information
75 %
100 %
7/7/2026
Continue to Enduring Material